Cytoreductive surgery and adjuvant immunotherapy: A new management paradigm for metastatic melanoma

被引:70
作者
Morton, DL [1 ]
Ollila, DW
Hsueh, EC
Essner, R
Gupta, RK
机构
[1] St Johns Hlth Ctr, John Wayne Ctr Inst, Santa Monica, CA USA
[2] Univ N Carolina, Chapel Hill, NC 27515 USA
[3] John Wayne Ctr Inst, Lab Prot Biochem & Tumor Markers, Santa Monica, CA USA
关键词
D O I
10.3322/canjclin.49.2.101
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although patients with metastatic disease are usually not offered surgery as part of their comprehensive treatment plan, the authors suggest that surgical reduction of the tumor burden may enhance the host immune response and create a favorable setting for the use of active specific immunotherapy.
引用
收藏
页码:101 / +
页数:17
相关论文
共 84 条
  • [41] LIVINGSTON PO, 1989, CANCER RES, V49, P7045
  • [42] MCCLAY EF, 1992, INT J CANCER, V50, P553
  • [43] CHANGING-ROLE OF SURGERY FOR PULMONARY METASTASES
    MCCORMACK, PM
    MARTINI, N
    [J]. ANNALS OF THORACIC SURGERY, 1979, 28 (02) : 139 - 145
  • [44] ACTIVE-SPECIFIC IMMUNOTHERAPY FOR MELANOMA
    MITCHELL, MS
    HAREL, W
    KEMPF, RA
    HU, E
    KANMITCHELL, J
    BOSWELL, WD
    DEAN, G
    STEVENSON, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (05) : 856 - 869
  • [45] MITCHELL MS, 1997, P AN M AM SOC CLIN, V16, pA494
  • [46] Vaccine therapy for malignant melanoma
    Morton, DL
    Barth, A
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 1996, 46 (04) : 225 - +
  • [47] MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392
  • [48] IMMUNOLOGICAL ASPECTS OF LUNG-CANCER
    MORTON, DL
    HOLMES, EC
    GOLUB, SH
    [J]. CHEST, 1977, 71 (05) : 640 - 643
  • [49] PROLONGATION OF SURVIVAL IN METASTATIC MELANOMA AFTER ACTIVE SPECIFIC IMMUNOTHERAPY WITH A NEW POLYVALENT MELANOMA VACCINE
    MORTON, DL
    FOSHAG, LJ
    HOON, DSB
    NIZZE, JA
    WANEK, LA
    CHANG, C
    DAVTYAN, DG
    GUPTA, RK
    ELASHOFF, R
    IRIE, RF
    [J]. ANNALS OF SURGERY, 1992, 216 (04) : 463 - 482
  • [50] MORTON DL, 1997, CANC MED, P651